
David F Gardiner MD FACP
Executive Director & Global Product Leader Hizentra & Privigen Immunology, CSL Behring
Join to view full profile
1040 1st AveKing of Prussia, PA 19406
Phone+1 267-355-4898
Dr. Gardiner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2001 - 2004
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1997 - 2001
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997
Certifications & Licensure
NY State Medical License 2001 - Present
PA State Medical License 2000 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 8 citationsModelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batchesSara Stinca, Thomas W. Barnes, Peter Vogel, Wilfried Meyers, Johannes Schulte-Pelkum
Plos One. 2021-11-29 - Correction to: Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK...Andrea Nuzzo, Stephanie Van Horn, Christopher Traini, Caroline R Perry, Etienne F Dumont
BMC Microbiology. 2021-10-26 - 10 citationsComparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague.Dung Nguyen, Jafar Sadik Shaik, Guoying Tai, Courtney Tiffany, Caroline R Perry
British Journal of Clinical Pharmacology. 2021-09-02
Press Mentions
Haemolytic Uraemic Syndrome (HUS)November 27th, 2018
Grant Support
- A Novel Vaccine Targeting HIV GP41 SequencesNational Institute Of Allergy And Infectious Diseases2004–2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: